Summary The cytoplasmic domain of cadherins is known to associate with the intracellular proteins, catenins, which link cadherins to the actin-based cytoskeleton. In this study, we immunohistochemically investigated the expression of f-catenin as well as E-cadherin and a-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors. In cancerous tissues, the frequency of reduced expression of ,B-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of a-catenin (47 of 86, 55%). All three molecules were expressed strongly, as was the normal epithelium, in 36 cases (42%), whereas the rest (50 cases, 58%) showed reduction in one of the molecules. The reduction of ,B-catenin expression was significantly correlated with dedifferentiation, Duke's stage, lymph node metastasis and liver metastasis. Next, we examined tyrosine phosphorylation in the protein complex immunoprecipitated with E-cadherin, as E-cadherin function is down-regulated by receptor-type tyrosine kinase in vitro. It was of interest that up-regulation of tyrosine phosphorylation of ,B-catenin was more frequently observed in cancerous tissues than in the matching normal mucosa.
HSC-39 cells, in spite of the existence of E-cadherin (Kawanishi et al, 1995) . Other studies demonstrated that 1-catenin was tyrosine phosphorylated in a cadherin-catenin complex and that elevation of tyrosine phosphorylation of f-catenin appears to be associated with cadherin dysfunction in vitro Behrens et al, 1993; Hamaguchi et al, 1993) .
Recently, 3-catenin has been proved to play a different role in embryonic morphogenesis. For example, f-catenin is involved in axis determination in Xenopus embryos, and Armadillo, a Drosophila homologue of f-catenin, is essential for establishment of segment polarity (McCrea et al, 1991) . These signals may be different from cadherin-mediated cell adhesion, as they are generated by a growth factor, Wnt (or its Drosophila homologue, Wingless), and require cytosolic f-catenin not bound to Ecadherin (McCrea et al, 1993; Hinck et al, 1994) . In addition, it was reported recently that the APC (adenomatous polyposis coli) tumour-suppressor gene product forms a complex with f-catenin, and disruption of this complex is a crucial step in colorectal carcinogenesis (Rubinfeld et al, 1993; Su et al, 1993) . In consequence, mutation in either APC or f-catenin leads to the accumulation of cytosolic f-catenin, which binds to T-cell factor (Tcf) and lymphoid enhancer factor (Lef) transcription factors Morin et al, 1997; Rubinfeld et al, 1997) Although we have shown that reduced expression of f-catenin has been frequently observed in human cancers, its significance in vivo is quite unknown (Takayama et al, 1996) . In this study, we immunohistochemically investigated the expression of f-catenin and revealed that reduced expression of f-catenin is significantly correlated with tumour invasion and metastasis in colorectal cancer tissues. In addition, we examined the tyrosine phosphorylation of 3-catenin using immunoprecipitation and Western blot, and we found an increase in P-catenin phosphorylation in cancer cells compared with normal epithelium. Thus, this is the first study to thoroughly investigate the role of 3-catenin using in vivo cancer tissues. We also discuss here the possible implication of P-catenin in carcinogenesis and progression.
MATERIAL AND METHODS Patients
Eighty-six patients with colorectal cancer who underwent surgery at the Second Department Surgery, Osaka University, were investigated in this study. None of them received anti-cancer therapy preoperatively. Samples for immunohistochemistry were taken from representative cancerous lesions, including adjacent noncancerous mucosa. Samples for Western blotting and immunoprecipitation were also obtained from the tumour and normal mucosa, avoiding contamination from the underlying connective tissues. They were frozen in liquid nitrogen for less than 1 h after surgical resection.
Antibodies
The following antibodies were used in this study: mouse monoclonal antibody (MAb) against human E-cadherin (HECD-1) purchased from Takara Shuzo (Shiga, Japan), rat MAb against acatenin (oc-18) provided by A Nagafuchi. The rabbit polyclonal antibody against P-catenin was raised by immunization with synthetic peptides located in the COOH-terminal of 14 amino acids of ,-catenin conjugated with a keyhole limpet haemocyanine (KLH), as described previously (Shibamoto et al, 1995 
Evaluation of immunostaining
In cancerous tissues, the intensity of 3-catenin, E-cadherin and acatenin was evaluated compared with normal epithelial cells in the same section as an internal positive control. As we did not observe protein overexpression of any of these three molecules, their expression was classified as follows. When the intensity of tumour cells was equal to the normal epithelial cells, the expression of the tumour cells was evaluated as being preserved (+). When the intensity of staining was homogeneously weak or variable, the expression of the tumour cells was evaluated as being reduced (±) (Shibamoto et al, 1995) .
Histological findings and statistics
A consecutive section from each specimen was stained with haematoxylin and eosin for histological evaluation. The clinicopathological stage was classified according to the modified Duke's classification (Dukes, 1932; Dukes and Bussey, 1958; Enker et al, 1979) . The correlation between 3-catenin expression and clinicopathological features was evaluated using both the Spearman rank correlation coefficient and Fisher's exact test. P < 0.05 was considered as being statistically significant.
Immunoblot analysis
The tumour and normal mucosa were homogenized in a lysis buffer (50 mM Tris-HCl pH 7.5, 1% Nonidet P-40, 0.1% sodium deoxycholate, 2 mm calcium chloride) and clarified by centrifugation. Then, protein concentration was determined with the Bradford protein assay kit (Bio-Rad, CA, USA). Fifty milligrams of protein sample was mixed with the same amount of loading buffer (20% glycerol, 4.6% sodium dodecyl sulphate (SDS), 125 mm Tris-HCl pH 6.8). After boiling for 5 min in the presence of 2-mercaptoethanol, the lysate was separated by 7.5%
British Journal of Cancer (1998) 77 (4), [605] [606] [607] [608] [609] [610] [611] [612] [613] . Cancer Research Campaign 1998 SDS-polyacrylamide gels and transferred to Immobilon polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA, USA). After blocking with 5% skimmed milk, or 1% bovine serum albumin (BSA) for phosphotyrosine, the membranes were incubated with the appropriate primary antibodies for 2 h at room temperature. The filters were washed and incubated with the appropriate alkaline phosphatase-conjugated secondary antibodies (Promega, Madison, WI, USA) and developed with the ProtoBlot NBT and BCIP Color Development System (Promega, Madison, WI, USA).
Immunoprecipitation
One hundred milligrams of tumour tissues and matching normal mucosa were homogenized in 1.0 ml of extraction buffer (0.5% Nonidet P-40, 0.1% SDS, 2 mm phenylmethylsulphonyl fluoride, 2 mm calcium chloride, 1 mm sodium orthovanadate, 3 mM hydrogen peroxide, 2 jg of leupeptin, 2 jg of pepstatin A, 1 ,ug of aprotinin in 50 mM Tris-buffer saline pH 7.4) and centrifuged at 15 000 r.p.m. for 20 min at 4°C. Two hundred micrograms of total cell lysate were preabsorbed by incubation with 50 ,ul of protein A sepharose (Pharmacia LKB Biotechnology, Uppsala, Sweden) for 30 min. The supernatant was mixed with 4 ,ug of HECD-1 or 4 ,ug of 3-catenin for 2 h and then incubated with the protein A sepharose for 2 h. The beads were collected by centrifugation, washed five times with the extraction buffer, then suspended in 200,ul of the loading buffer (20% glycerol, 4.6% SDS, 125 mM Tris-HCI pH 6.8) with 5% 2-mercaptoethanol and boiled for 5 min. The released materials were analysed by immunoblotting.
Analysis of tyrosine phosphorylation of P-catenin (Molecular Dynamics, Sunnyvale, CA, USA). The tyrosine phosphorylation index of P-catenin was calculated by dividing the density of the 95 kDa band in the phosphotyrosine immunoblot, which was supposed to be tyrosine phosphorylated 3-catenin, by that at the same position on the P-catenin immunoblot. Subsequent data are presented as the ratio of the tyrosine phosphorylation index of P-catenin between the tumour and the matching normal mucosa.
RESULTS
Immunostaining of 0--catenin and its correlation with clinicopathological factors
The normal large bowel epithelium strongly expressed 3-catenin, E-cadherin and a-catenin at the cell-cell boundaries without exception. In P-catenin(+) tumours, f-catenin was similarly expressed at the cell-cell boundaries. On the other hand, ,Bcatenin(±) tumours showed obscure or diffuse expression in the cytoplasm (Figure 1 ). According to our criteria, 58 of the colorectal tumours were classified as P-catenin(+) (58 of 86, 67%) and 28 tumours were classified as P-catenin(±) (28 of 86, 33%). Table 1 shows the relationship between P-catenin expression and the clinicopathological factors.
The frequency of 1-catenin(+) in the well-differentiated type (84%, 31 of 37) was higher than in the moderately differentiated (53%, 21 of 40) or in the poorly differentiated type (67%, six of nine). Thus, there was a significant positive correlation between the reduced P- Correlation between E-cadherin/I-catenin/u-catenin expression patterns and metastasis 3-Cateinin has been repor-ted to form a complex with cadherini anid u-catenin, and this binding is necessary for complete cell adhesion mediated by cadherin. Therefore, we immunohistochemically investigated not only the expression of 3-catenin but also that of E-cadherin and ax-catenin.
The coexpression pattern of these three molecules is summarized in Table 2 . Expression of E-cadherin and u-catenin was reduced in 19 tumours and 47 tumours respectively. The frequencies of E-cadherin(+) (22%) and P-catenin(+) (33%) were similar, but the reduction of (x-catenin (55%) was more frequent than that of the others. As the assembly of these three molecules has been recently revealed, we designed the coexpression pattern in the order of E-cadherin-S-catenin-a-catenini. Thirty-six tumours Figure 3A ). In addition, we compared the frequency of metastasis Figure  3B ). This frequency of metastasis was similar (ranging from 67-92%), although it was a little higher in the tumours with Ecad(±)/P-cat(±)/oc-cat(±) than in other patterns.
Tyrosine phosphorylation in immunoprecipitates with E-cadherin
The protein complex of E-cadherin, f-catenin and a-catenin was observed not only in the normal epithelium but also in the representative E-cadherin(+) tumours (Figure 4 ). In addition, we identified that y-catenin also formed a complex with E-cadherin (data not shown). As tyrosine phosphorylation of this complex caused a decline of E-cadherin-mediated adhesion in vivo, we examined it in colorectal cancer tissues and matching normal mucosa. Fourteen tumours, including 13 E-cad(+) and one E-cad(±), and their matching normal mucosa were used for immunoprecipitation. In the immunoprecipitates with E-cadherin, tyrosine phosphorylation at the 95-kDa band, which is identical to ,B-catenin, was observed, while tyrosine phosphorylation of E-cadherin or a-catenin was not detectable. Interestingly, tyrosine phosphorylation at the 95 kDa band was recognized not only in cancerous tissues but also in the normal mucosa ( Figure 5 ). The tyrosine phosphorylation index of 1-catenin were calculated by anti-1-catenin and anti-phosphotyrosine immunoblots with the f-catenin immunoprecipitant. The tyrosine phosphorylation index ratios between the tumours and the matching normal mucosa are summarized in Table 3 . This ratio has been proved to be reproducible in preliminary experiments (standard deviations were 0.140 and 0.151 in triplicate experiments using two different tissue samples) (data not shown). The tyrosine phosphorylation index of f-catenin in cancerous tissues was similar to that in the normal mucosa in 3 of 14 (21 %) cases (within 2 s.d.) and higher in 11 (79%) of 14 cases, hence the difference between the tumour and the normal mucosa was statistically significant (P < 0.05). However, no significant correlation was found between clinical staging and the tumour-normal ratios of the tyrosine phosphorylation index of P-catenin.
DISCUSSION
We and other investigators have demonstrated that the decline of the E-cadherin cell adhesion molecule directly resulted in tumour invasion in vivo, and this has a strong correlation with tumour invasion and metastasis in human cancer tissues (Shiozaki et 1991; Oka et al, 1992 Oka et al, , 1993 ). E-cadherin is known to form a complex with several cytoplasmic proteins, including a-, 1-, ycatenins and p120, and to be connected finally to the actin filaments (Ozawa et al, 1989; Shibamoto et al, 1995) . The lack of normal a-catenin has been observed in the cultured cell lines PC 9 and PC 3, and it caused dysfunction of E-cadherin-mediated adhesion (Shimoyama et al, 1992; Morton et al, 1993) . In addition, we have shown that the reduced expression of a-catenin in human cancer tissues is frequent and is strongly associated with tumour invasion and metastasis Shiozaki et al, 1994; Takayama et al, 1994 ). Thus, not only E-cadherin but also acatenin are key molecules that control tumour invasion and metastasis through disturbance of intercellular adhesions. For a long time, the role of ,B-catenin in the cadherin adhesion system was not understood. However, the assembly of cadherin and associated proteins has recently been elucidated. In the intercellular adherence junction, the cytoplasmic domain of cadherin is bound to ,B-catenin, which is also bound to the amino terminal of a-catenin at another site (Aberle et al, 1994; Nagafuchi et al, 1994) . Then, the carboxyl terminal of a-catenin is directly bound to actin filament or is indirectly bound to actin through a-actinin (Knudsen et al, 1995) . 1-Catenin, as well as a-catenin, are indispensable for cadherin-mediated cell adhesion, as mutation of 1-catenin in HSC-39 and -40 human gastric cancer cells causes impaired E-cadherin function (Oyama et al, 1994; Kawanishi et al, 1995) . However, mutation of the 1-catenin gene has not been found in human cancer tissues but only in cultured cell lines (Candidus et al, 1996) . Nevertheless, we have often observed reduced protein expression by immunohistochemistry and immunoblotting in human cancer tissues. This might imply that the reduced protein expression of 1-catenin is due to a transcriptional or post-transcriptional event in vivo. In this study, using human colon cancer specimens obtained by surgery, we tried to elucidate the clinical significance of 1-catenin expression and to compare it with E-cadherin and a-catenin expression.
Reduced expression of ,B-catenin was observed in 33% (28 of 86) of colon cancer tissues, and this had a significant correlation with dedifferentiation, lymph node metastasis, liver metastasis and advanced stages in Duke's classification. Disruption of intercellular adhesion is considered to be necessary for all these phenotypes. Among E-cadherin, 1-catenin and a-catenin, reduced expression of a-catenin was the most frequent. Previous studies have shown that a-catenin has to be linked to E-cadherin to prevent protein degradation, while both E-cadherin and 1-catenin can exist without forming a protein complex (Shimoyama et al, 1992; Nagafuchi et al, 1994) . Therefore, disorder of either Ecadherin or ,B-catenin might secondarily induce reduction of acatenin. The coexpression pattern of these three molecules is almost compatible with this hypothesis. In our study, 94% of the tumours (47 of 50) with an abnormal coexpression pattern had a reduced a-catenin expression alone or with concomitant reduction in the expression of E-cadherin and/or 13-catenin. However, there were three exceptional cases; these expressed a-catenin with a reduction in 1-catenin [E-cad (+), 1-cat (±), a-cat (+)]. In these cases, y-catenin might have substituted for 1-catenin to form a complex with E-cadherin and a-catenin. We also found six tumours with E-cad (±), ,3-cat (+), a-cat (±). Beta-catenin in these tumours is not involved in E-cadherin-mediated intercellular adhesion. Hence, it is of interest to elucidate the function of 1-catenin in these tumours.
Recently, it was revealed that ,B-catenin is involved not only in the cadherin cell adhesion system but also in the growth signal pathway. The signals generated by Wingless or its vertebral homologue Wnt, which is essential for embryonal organization, induce protein expression of 1-catenin. The role of 1-catenin downstream of Wnt seems to be different from that in cadherin-mediated cell adhesion because this ,B-catenin, induced by Wnt, exists in cytosol without binding to cadherin (McCrea et al, 1993) . Moreover, overexpression of truncated ,B-catenin, which cannot bind with acatenin, has an effect in embryogenesis similar to that of the wild type of 1-catenin or growth signal of Wnt (Funayama et al, 1995) .
Wnt also acts as an oncogene in human mammary carcinogenesis (Kwan et al, 1992) . Therefore, it might be of interest to investigate Wnt expression in this type of cancer.
It has been demonstrated that 1-catenin binds with the APC tumour-suppressor gene product in the cytoplasm, and this complex does not include cadherin . The APC gene is mutated in 80% of colorectal cancer cases (Miyoshi et al, 1992) . Interestingly, most mutations occurred at the P-catenin binding site . The wild type of APC has little effect on the 1-catenin binding with cadherin, but it decreases the protein content of the cytosolic-free ,B-catenin . The function of APC as a tumour-suppressor gene might bind and limit the cytosolic-free 1-catenin. ,B-catenin in this status British Journal of Cancer (1998) 77(4), 605-613 binds to Tcf and Lef transcription factors, which play key roles downstream of the Wingless signal Rubinfeld et al, 1997) . The association of APC mutation and cytoplasmic j-catenin expression has been studied in colorectal polyps (Inomata et al, 1996) . Further study concerning cytoplasmic 3-catenin and transcription factors may be required in the future.
Beside the reduction of protein expression, another disorder of 0-catenin is observed in cancer cells. Tyrosine phosphorylation of 0-catenin is observed in the cell transformed with v-src, and it counteracts E-cadherin-mediated junctional assembly Behrens et al, 1993; Hamaguchi et al, 1993) . We reported a similar effect in oncogenic stimulation through epidermal growth factor receptor or hepatocyte growth factor receptor Shiozaki et al, 1995) . In previous studies, tyrosine phosphorylation of P-catenin was considered to be characteristic of cancer cells. However, in this study, it was observed in the non-cancerous colon epithelium, although the amount was less than that in cancer cells.
The amount of tyrosine phosphorylated 0-catenin showed some diversity among tumours, but there were no significant correlations between tyrosine phosphorylation of 0-catenin and the clinicopathological factors. Takeda et al (1995) reported that tyrosine phosphorylation of f-catenin is not required for the dysfunction of cadherin-based cell adhesion in the introduction of the v-src model. On the other hand, Kinch et al (1995) reported that the elevation of tyrosine-phosphorylated 3-catenin attenuated the connection between E-cadherin and 3-catenin. Thus, although tyrosine phosphorylation of 3-catenin is parallel to the decline of cadherin-mediated adhesion, the direct interaction is still controversial, and the mechanism is still not well understood. Further studies are required to understand the clinical significance of tyrosine-phosphorylated 3-catenin in vivo.
In conclusion, our findings suggest that the frequent reduction of a-and 3-catenin, which causes dysfunction in the E-cadherinmediated adhesion complex, may play a critical role in cancer invasion and metastasis. In addition, tyrosine phosphorylation of 3-catenin may participate in regulation of the cadherin-catenin complex in vivo. These results suggest that 3-catenin may have important regulatory roles in the E-cadherin-mediated adhesion system in human colorectal cancers.
